Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology.
about
Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matricesScreening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition.Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.Quantitative analysis of cortisol and 6β-hydroxycortisol in urine by fully automated SPE and ultra-performance LC coupled with electrospray and atmospheric pressure chemical ionization (ESCi)-TOF-MS.Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept.Rapid, simple, and highly sensitive analysis of drugs in biological samples using thin-layer chromatography coupled with matrix-assisted laser desorption/ionization mass spectrometry.Towards a universal LC-MS screening procedure - can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument?Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.Clinical Validation of a Highly Sensitive GC-MS Platform for Routine Urine Drug Screening and Real-Time Reporting of up to 212 Drugs.Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry.Systematic forensic toxicological analysis by GC-MS in serum using automated mass spectral deconvolution and identification system.Differentiation of oral bacteria in in vitro cultures and human saliva by secondary electrospray ionization - mass spectrometry.Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimensCurrent role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods.The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation.Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.Multi-target screening of biological samples using LC-MS/MS: focus on chromatographic innovations.Chemiluminescence microarrays in analytical chemistry: a critical review.Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.A new metabolomics-based strategy for identification of endogenous markers of urine adulteration attempts exemplified for potassium nitrite.Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS.Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS.Quantification of 31 illicit and medicinal drugs and metabolites in whole blood by fully automated solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry.Do we need high-resolution MS in forensic and clinical toxicology?Pitfall in cannabinoid analysis--detection of a previously unrecognized interfering compound in human serum.Determination of cocaine and metabolites in hair by column-switching LC-MS-MS analysis.Pressurized-liquid extraction for determination of illicit drugs in hair by LC-MS-MS.Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer.Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry.Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmorphine and reduction of analytes.Simultaneous Quantitation of Methamphetamine, Ketamine, Opiates and their Metabolites in Urine by SPE and LC-MS-MS.Sample preparation for large-scale bioanalytical studies based on liquid chromatographic techniques.Validation of a fast UPLC-MS/MS method for quantitative analysis of opioids, cocaine, amphetamines (and their derivatives) in human whole blood.Distribution measurement of amphetamine-type stimulants in organs using micropulverized extraction and liquid chromatography/tandem mass spectrometry to complement drug distribution using mass spectrometry imaging.Non-allowed Pharmacologically Active Substances in Physical and Sexual Performance Enhancing Products.Rapid identification of seized controlled substances and related compounds by tandem mass spectrometry without chromatography.Use of Xylazine in Drug-Facilitated Crimes.An alternative approach for assessment of liquid chromatography-mass spectrometry matrix effects using auto-sampler programmed co-injection.Thermodynamic-based retention time predictions of endogenous steroids in comprehensive two-dimensional gas chromatography.
P2860
Q21296806-826AE973-6F1E-4AD1-A287-C009C89F07A4Q30619552-3BCECE9C-1E6B-4B24-8221-C0BC0BAADE62Q31083824-99C47FFD-1882-4B32-87A3-DA456A81B33AQ33456702-3B064997-FD24-4AE8-981F-0C5BAAE003FCQ33887048-5DA32334-42A5-4252-8E42-A47BEA136811Q34093122-B52F9D05-F8D3-4053-BF98-8060C34F5207Q34142688-92619CE2-94E0-4170-84A2-EF556C6AD1B8Q34149545-DB9429CD-D208-4D86-841B-51C94ECC1521Q34532586-81651902-E23A-4979-AF6A-C39FA9D165FEQ34917423-653AE344-3577-4ED0-8B7C-6553A9AE971AQ35389892-DFA9D108-58A2-486C-949C-55E56CBABF50Q35762678-D9AC338C-5282-4BE3-9CAA-55C4F750679DQ36174628-8A3012FD-84ED-4F07-979E-92B7B292324AQ36647089-FE506C46-49F4-4CA7-93EC-9B4A1042F8E4Q37866806-8593E3FF-3769-4CA2-A212-64F26568E11CQ38012171-0A3339D8-7193-4788-93D8-3D1EE96B3D43Q38058053-D1A15A6F-1746-4D09-862D-1A1532F8C067Q38221657-B791AFF9-215D-4E1E-AE3B-814E3C272B2FQ38227132-BCDA83EC-3B96-446D-93B4-D3E0BE6A0C51Q38266517-A98BA951-28A4-46A9-B476-5A71172F2636Q38621081-6C73D089-6B84-4EED-8770-0F0467984AFAQ39157890-4F22879E-672D-4AB3-BE14-D4CC6177A4E2Q41199607-06CDC98C-FD4F-43F5-AF75-DC5390A46825Q44111548-7EDE3C23-560F-4050-A50E-EC311558CD52Q44258752-4654FB9F-2068-490D-A9AF-0E328CE8B2C9Q45164178-6241FF51-994B-4071-9723-F144F66CA7ABQ45217720-1FF2C4E2-541D-4DDE-B2AD-1796DCC9B01EQ45735623-E44B3B83-8498-4CC0-BD1B-E6B1014815A5Q45854049-6DE8D579-484F-4D05-911C-908F29970935Q46205509-D8C84214-BF68-463A-B12B-1785C6FC6A6DQ46579032-5BC4D2CB-FE1E-4848-8D62-ACC9094B5CA9Q47244313-B8632CCC-653C-460C-8575-031B9B99B105Q47396882-6D6A1623-CEE0-47CA-A1A1-1C3D35C8B956Q47634307-567DC199-A438-4F69-8A3B-4E742808BB19Q48904961-5BEB65DF-E643-4D33-982B-6F9BD3A0FBBEQ50233999-99A41C67-8005-406B-B1CA-3027B7675B16Q50693818-C8C0B22A-3972-491E-973B-D1C66034F5A2Q52817114-E9ACA691-4CF8-4C06-BC0C-4FBFFC6432FCQ53208088-D2CE177E-6915-4199-A6CF-89096F6DC62DQ53554138-1C7C01DD-BF30-4D22-BFA0-435C6A8302F0
P2860
Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances of liquid chromatography-
@nl
Recent advances of liquid chro ...... nical and forensic toxicology.
@en
type
label
Recent advances of liquid chromatography-
@nl
Recent advances of liquid chro ...... nical and forensic toxicology.
@en
prefLabel
Recent advances of liquid chromatography-
@nl
Recent advances of liquid chro ...... nical and forensic toxicology.
@en
P1476
Recent advances of liquid chro ...... nical and forensic toxicology.
@en
P2093
Frank T Peters
P356
10.1016/J.CLINBIOCHEM.2010.08.008
P577
2010-08-13T00:00:00Z